Optimizing cardiac cell therapy: From processing to delivery
نویسندگان
چکیده
منابع مشابه
Optimizing cardiac cell therapy: from processing to delivery.
966 The Journal of Thoracic and Cardio In this issue, McConnell and colleagues 1 report a detailed examination of the impact of autologous skeletal myoblast transplantation in a chronic ischemic cardiomyopathy model in sheep. They injected the cells prepared by GenVec, Inc, at multiple sites in the infarct zone. They concluded that cardiac contractility was not improved, but cell implantation p...
متن کاملOptimizing cell-based therapy for cardiac regeneration.
Long thought to be a terminally differentiated organ, recent findings suggest that the adult mammalian heart is a slowly regenerating organ1 and home to a resident population of cardiac progenitor cells (CPCs) that renew cardiomyocytes and have the potential to differentiate into multiple cell types within the myocardium.2 In spite of this, the regenerative capacity of the mammalian heart is in...
متن کاملOptimizing the Delivery of Radiation Therapy to Cancer Patients
In the field of radiation therapy, much of the research is aimed at developing new and innovative techniques for treating cancer patients with radiation. In recent years, new treatment machines have been developed that provide a much greater degree of computer control than was available with the machines of previous generations. One innovation has been the development of an approach called “tom...
متن کاملRole of Nanodiamonds in Drug Delivery and Stem Cell Therapy
Context: The use of nanotechnology in medicine and more specifically drug delivery is set to spread rapidly. Currently many substances are under investigation for drug delivery and more specifically for cancer therapy. Evidence Acquisition: Nanodiamonds (NDs) have contributed significantly in the development of highly efficient and successful drug delivery systems, and in stem cell therapy. Dru...
متن کاملCardiac Cell Therapy 3.0
Cardiac cell therapy (CCT) holds great promise as a regenerative medicine approach for the treatment of cardiovascular diseases (CVDs). The first generation of CCTs tested various adult cell types, including skeletal myoblasts, bone marrow (BM)–derived mesenchymal stem cells (MSCs), and cardiac progenitor cells (CPCs). More recently, the advent of induced pluripotent stem cells (PSCs) led to th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Thoracic and Cardiovascular Surgery
سال: 2005
ISSN: 0022-5223
DOI: 10.1016/j.jtcvs.2005.05.047